RUNX2 and Miyoshi myopathy: The variability in AP, RUNX2, SPARC and SPP1 expression and the disparate capacity for differentiation observed in the human and murine MM cell lines is also consistent with clinical observations, as not all patients with MM are reported to contain areas of osseous differentiation and bone formation.